Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis—A Case Report
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 11 (5) , 623-627
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Recurrent Pyroglutamic Acidosis Related to Therapeutic AcetaminophenThe American Journal of the Medical Sciences, 2018
- 5-Oxoprolinuria in hyperammonemic encephalopathy: Coincidence or worsening factor?Clinical Biochemistry, 2017
- Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot studyBMC Gastroenterology, 2017
- Pyroglutamic acidosis in association with therapeutic paracetamol useClinical Medicine, 2016
- Metabolic acidosis and 5-oxoprolinuria induced by flucloxacillin and acetaminophen: a case reportJournal of Medical Case Reports, 2016
- Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohortHepatology, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Prediction of liver cirrhosis, using diagnostic imaging toolsWorld Journal of Hepatology, 2015
- Acetaminophen Toxicity and 5-Oxoproline (Pyroglutamic Acid)Clinical Journal of the American Society of Nephrology, 2014
- Severe Liver Fibrosis or Cirrhosis: Accuracy of US for Detection—Analysis of 300 CasesRadiology, 2003